Literature DB >> 17010451

Involvement of specific orexigenic neuropeptides in sweetener-induced overconsumption in rats.

Yuichi Furudono1, Chiho Ando, Chizuko Yamamoto, Motoi Kobashi, Takashi Yamamoto.   

Abstract

Palatability is one of the factors that regulates food and fluid intake and contributes to overconsumption in turn contributing to obesity. To elucidate the brain mechanisms of the palatability-induced ingestion, we explored the roles of six hypothalamic orexigenic neuropeptides, orexin, melanin-concentrating hormone (MCH), neuropeptide Y (NPY), agouti-related protein (AgRP), ghrelin and dynorphin, in the intake of a palatable solution, saccharin. Of the six peptides, intracerebroventricular (i.c.v.) administrations of orexin, MCH and NPY increased the intake of saccharin. Drinking of saccharin in turn elevated the mRNA levels of orexin and NPY, but not MCH. Pre-treatments of naloxone, an opioid antagonist, blocked the orexigenic effects of orexin and NPY. Specific gastric motor responses induced by central orexin-A and NPY are well known, however, MCH did not induce such responses. The i.c.v. administration of orexin-A facilitated gastric emptying. These results suggest that the overconsumption promoted by sweet and palatable tastes is attributed to the activation of orexigenic neuropeptides, such as orexin and NPY, and a downstream opioid system together with enhanced digestive functions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17010451     DOI: 10.1016/j.bbr.2006.08.031

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  23 in total

Review 1.  Behavioral controls of food intake.

Authors:  Stephen C Benoit; Andrea L Tracy
Journal:  Peptides       Date:  2008-01       Impact factor: 3.750

Review 2.  Endogenous opiates and behavior: 2006.

Authors:  Richard J Bodnar
Journal:  Peptides       Date:  2007-09-11       Impact factor: 3.750

Review 3.  Novel functions of orexigenic hypothalamic peptides: from genes to behavior.

Authors:  Stephen C Benoit; Andrea L Tracy; Jon F Davis; Derrick Choi; Deborah J Clegg
Journal:  Nutrition       Date:  2008-09       Impact factor: 4.008

Review 4.  Analysis of the network of feeding neuroregulators using the Allen Brain Atlas.

Authors:  Pawel K Olszewski; Jonathan Cedernaes; Fredrik Olsson; Allen S Levine; Helgi B Schiöth
Journal:  Neurosci Biobehav Rev       Date:  2008-03-29       Impact factor: 8.989

Review 5.  Neurobiology of consummatory behavior: mechanisms underlying overeating and drug use.

Authors:  Jessica R Barson; Irene Morganstern; Sarah F Leibowitz
Journal:  ILAR J       Date:  2012

Review 6.  Orexin/Hypocretin System: Role in Food and Drug Overconsumption.

Authors:  Jessica R Barson; Sarah F Leibowitz
Journal:  Int Rev Neurobiol       Date:  2017-08-08       Impact factor: 3.230

7.  Expression levels of genes encoding melanin concentrating hormone (MCH) and MCH receptor change in taste aversion, but MCH injections do not alleviate aversive responses.

Authors:  Anaya Mitra; Anica Klockars; Blake A Gosnell; Madeleine Le Grevès; Pawel K Olszewski; Allen S Levine; Helgi B Schiöth
Journal:  Pharmacol Biochem Behav       Date:  2011-09-07       Impact factor: 3.533

8.  Effects of hindbrain melanin-concentrating hormone and neuropeptide Y administration on licking for water, saccharin, and sucrose solutions.

Authors:  John-Paul Baird; Catalina Rios; Jasmine L Loveland; Janine Beck; Alice Tran; Carrie E Mahoney
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2007-11-07       Impact factor: 3.619

9.  Attenuation of saccharin-seeking in rats by orexin/hypocretin receptor 1 antagonist.

Authors:  Angie M Cason; Gary Aston-Jones
Journal:  Psychopharmacology (Berl)       Date:  2013-03-15       Impact factor: 4.530

10.  Hypothalamic injection of non-opioid peptides increases gene expression of the opioid enkephalin in hypothalamic and mesolimbic nuclei: Possible mechanism underlying their behavioral effects.

Authors:  Olga Karatayev; Jessica R Barson; Guo-Qing Chang; Sarah F Leibowitz
Journal:  Peptides       Date:  2009-09-24       Impact factor: 3.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.